A Pilot Study of 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer
Trial ID or NCT#
Status
Purpose
The objective of the study is to evaluate 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for biopsy guidance in patients with suspected prostate cancer.
Official Title
A Pilot Study of 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer
Eligibility Criteria
- - Suspected prostate cancer - Planned prostate biopsy - Able to provide written consent - Karnofsky performance status of 50 (or ECOG/WHO equivalent)
- - Patients not capable of getting PET study due to weight, claustrophobia, or inability to lay still for the duration of the exam - Metallic implants (contraindicated for MRI)
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Brittney Williams
650-736-3688
View on ClinicalTrials.gov